MARSEILLE, France & HOUSTON--(BUSINESS WIRE)--Mar 5, 2019--Vect-Horus and RadioMedix announced today the signing of a Letter of Intent (LOI) to establish an agreement for the co-development of a Vect-Horus theranostic agent for the diagnostic and radiotherapy of Glioblastoma Multiforme (GBM) of the brain. This press release features multimedia. View the full release here:...

Subscribe to Channel➡️ http://smarturl.it/Subscribe2019 || http://Instagram.com/Julianspromos
DOWNLOAD: http://julianspromos.com/practice
Performed by GBMNutron
Written and Produced by GBM Productions
Stay Connected with GBMNutron on Social Media!
Facebook: Gbmnutron
Instagram: gbmnutron
Twitter: